Boston Scientific (NYSE:BSX) sought to dispel concerns that its thinner next-generation stents may be more prone to crumpling than some other models with the release of results from 2 randomized clinical trials which found no instances of deformation with the med-tech titan’s newest stents.
Research & Development
MassDevice.com +3 | The top 3 med-tech stories for March 26, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
ACC roundup: The top headlines from today’s meeting of American College of Cardiology
Weight loss study: Bariatric surgery may treat Type 2 diabetes better than medicine
Gastric bypass and sleeve gastrectomy devices may be more effective in treating Type II diabetes than medication, according to a new study released at the annual meeting of the American College of Cardiology in Chicago today.
ACC 2012: Medtronic and Edwards rise on lower stroke rates in new TAVI data
ACC 2012: TAVI stands up to surgery at 2 years, but valve leak risk increases
Stent Wars: DES best bare metal stents
Updated March 26, 2012 at 9:23 a.m. with new details on Promus/Xience private label deal and March 23, 2012 at 1:15 p.m. with comments from Medtronic.
FDA wrestles with mobile medical apps and self-screening devices | MassDevice.com On Call
MASSDEVICE ON CALL — The FDA will meet this month to consider the role the agency will play in mobile medical technologies and patient-driven screening and diagnostics.
The agency forecasts that patients will soon have access to technologies that allow them to self-screen for diseases or conditions via stand-alone kiosks or wireless diagnostic tools like blood pressure readers and blood glucose readers.
Philips, B.D., Schein, Coloplast make the list for world’s most ethical | MassDevice.com On Call
MASSDEVICE ON CALL — The 2012 list of the world’s most ethical companies included a handful of medical device makers and group purchasing organizations, according to the research-based Ethisphere Institute.
MassDevice.com +3 | The top 3 med-tech stories for March 15, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Study: Heart hole closure no better than meds for preventing stroke | MassDevice.com On Call
MASSDEVICE ON CALL — A catheter-based procedure to close holes in patients’ hearts proved no better at preventing recurrent strokes than medication alone, according to a study published today in the New England Journal of Medicine.
Researchers compared use of NMT Medical’s StarFlex septal closure system with drug therapy against drug therapy alone, concluding that there were no statistically significant differences in stroke prevention between the 2 options for patients with patent foremen ovale, a hole between the upper chambers of the heart.